Immunovaccine Receives FDA Fast Track Designation for DPX-Survivac for Treatment of Ovarian Cancer
December 10, 2014 07:00 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 10, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that...
Immunovaccine Receives Final Approval to Graduate to TSX
November 24, 2014 17:23 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 24, 2014) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today...
Health Canada Clears Immunovaccine to Conduct Phase II Clinical Trial of DPX-Survivac in Recurrent Lymphoma
November 19, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 19, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today announced...
Immunovaccine Announces Financial Results for Quarter Ended September 30, 2014
November 14, 2014 16:39 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 14, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
Immunovaccine Receives Conditional Approval to Graduate to Toronto Stock Exchange (TSX)
November 12, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 12, 2014) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today...
Immunovaccine Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine
October 21, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 21, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today announced positive...
Immunovaccine to Provide Update on Ongoing Ebola Virus and Cancer Vaccine Programs at 13th Annual BIO Investor Forum
October 06, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Announces Changes to Stock Option Plan
October 06, 2014 08:00 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Announces Plans for Phase II Clinical Trial of DPX-Survivac in Patients with Recurrent Lymphoma
October 01, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 1, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today provided a...
Immunovaccine Adds Broad Business Operations and Capital Raising Expertise to Board of Directors with New Appointments
September 26, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 26, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy...